SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions
Frontiers in Cell and Developmental Biology · 05.08.2026 · 14
DOI: 10.3389/fcell.2026.1912468 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 05.08.2026. Verfasst von Bo Pang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, First Hospital of Jilin University, Changchun, Jilin, China. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Secreted Phosphoprotein 1 (SPP1) is a multifaceted matricellular glycoprotein that mediates diverse biological processes via integrin and CD44 receptor signaling. While its profound contributions to tumor progression and metastasis are extensively documented, emerging evidence underscores its pivotal roles across diverse non-cancerous conditions, including pregnancy-related complications, fibrotic diseases and neurological disorders. Crucially, SPP1 exhibits functional pleiotropy, orchestrating angiogenesis and epithelial-mesenchymal transition, while modulating immunosuppression. These collective actions drive disease progression, establishing SPP1 as a compelling therapeutic target. This review synthesizes current understanding of SPP1 biology, highlighting mechanistic insights imperative for translating its therapeutic potential into safe, precision-targeted interventions against diverse SPP1-driven pathologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, First Hospital of Jilin University, Changchun, Jilin, China.
- Electrodiagnosis Department, Qianwei Hospital of Jilin Province, Changchun, China.
- Department of Reproductive Medicine, Hezhou People's Hospital of Guangxi Zhuang Autonomous Region, Hezhou, China.
- Reproductive Medicine Center, Prenatal Diagnosis Center, First Hospital of Jilin University, Changchun, Jilin, China.
Zitieren
APA
Pang, B., Sun, H., Ouyang, M., & Hu, C. (2026). SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1912468
Vancouver
Pang B, Sun H, Ouyang M, Hu C. SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1912468
BibTeX
@article{Pang2026,
author = {Pang, Bo and Sun, Huan and Ouyang, Mingyu and Hu, Cong},
title = {SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1912468}
}
EUVIMED